Q32 Bio Inc. Share Price
QTTBQ32 Bio Inc. Stock Performance
Open $3.55 | Prev. Close $3.57 | Circuit Range N/A |
Day Range $3.25 - $3.69 | Year Range $1.34 - $28.06 | Volume 13,991 |
Average Traded $3.52 |
Q32 Bio Inc. Share Price Chart
About Q32 Bio Inc.
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.
Q32 Bio Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
04-Dec-25 | $3.55 | $3.61 | +0.00% |
04-Dec-25 | $3.55 | $3.61 | +6.49% |
02-Dec-25 | $3.81 | $3.39 | -11.72% |
01-Dec-25 | $4.24 | $3.84 | +76.15% |
28-Nov-25 | $2.07 | $2.18 | +4.81% |
26-Nov-25 | $2.10 | $2.08 | +2.97% |
25-Nov-25 | $2.02 | $2.02 | -2.42% |